CLINICAL_TRIALS
trial_result
· 2024-07-31
Clinical Trial Update: Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib
Summary
Completed clinical trial evaluating trends in quality of life for patients with idiopathic pulmonary fibrosis treated with nintedanib; results were posted in 20…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED | Results posted: 2024-07-31